STOCKSCOUTER

StockScouter Premium

StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance

FLGT FULGENT GENETICS INCORPORATED StockScouter® Report

6

StockScouter® Score

FULGENT GENETICS INCORPORATED, a small cap growth company in the healthcare sector, is expected to slightly outperform the market over the next six months with slightly less than average risk

10 is the best possible rating. Learn more.

Summary

Positives

  • Earnings growth in the past year has accelerated moderately compared to earnings growth in the past three years. Positive
  • The most recent quarterly earnings report was significantly higher than analysts’ consensus forecast. Positive

 

Concerns

  • Two or more executives, directors or major shareholders – including one high-level executive –sold a small number of shares recently. Very negative
  • Shares are being sold by financial institutions. Slightly negative for a small company like FLGT

 

Short-term Outlook

Over the next 1-2 months, StockScouter forecasts that small cap stocks will be neutral, growth stocks will be in favor, and healthcare stocks will be neutral.

Expected Risk/Return

Progress: 40% done.
Progress: 80% done.
Low
High

Core Model Grades

A
D
B
B

Previous Ratings

6
9
7